Certified by Founder Lodge
Be Biopharma
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $82,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Be Bio is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, cancer, and other serious co
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 23 ,2024 | Unknown | $82,000,000 |
ARCH Venture Partners
Atlas Venture
RA Capital Management, L.P.
Takeda Ventures, Inc.
Bristol Myers Squibb
Longwood Fund
Alta Partners
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Cascade AI | $3,750,000 | (Oct 25, 2024)
OLOID | $6,000,000 | (Oct 25, 2024)
Outrider | $62,000,000 | (Oct 25, 2024)
Attention | $14,000,000 | (Oct 25, 2024)
Aether Energy (YC W24) | $2,500,000 | (Oct 25, 2024)
